Bovine Tuberculosis in Cattle: Vaccines, DIVA Tests, and Host Biomarker Discovery
- 15 February 2016
- journal article
- review article
- Published by Annual Reviews in Annual Review of Animal Biosciences
- Vol. 4 (1) , 87-109
Abstract
Bovine tuberculosis remains a major economic and animal welfare concern worldwide. Cattle vaccination is being considered as part of control strategies. This approach, used alongside conventional control policies, also requires the development of vaccine-compatible diagnostic assays to distinguish vaccinated from infected animals (DIVA). We discuss progress made on optimizing the only potentially available vaccine, bacille Calmette Guérin (BCG), and on strategies to improve BCG efficacy. We also describe recent advances in DIVA development based on the detection of host cellular immune responses by blood-testing or skin-testing approaches. Finally, to accelerate vaccine development, definition of host biomarkers that provide meaningful stage-gating criteria to select vaccine candidates for further testing is highly desirable. Some progress has also been made in this area of research, and we summarize studies that defined either markers predicting vaccine success or markers that correlate with disease stage or severity.Keywords
This publication has 112 references indexed in Scilit:
- Profiling microRNA expression in bovine alveolar macrophages using RNA-seqVeterinary Immunology and Immunopathology, 2013
- Bovine tuberculosis vaccine research: Historical perspectives and recent advancesVaccine, 2012
- Improved Skin Test for Differential Diagnosis of Bovine Tuberculosis by the Addition of Rv3020c-Derived PeptidesClinical and Vaccine Immunology, 2012
- Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infectionProceedings of the National Academy of Sciences, 2011
- Identification of Surrogates and Correlates of Protection in Protective Immunity againstMycobacterium bovisInfection Induced in Neonatal Calves by Vaccination withM. bovisBCG Pasteur andM. bovisBCG DanishClinical and Vaccine Immunology, 2011
- Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calvesVaccine, 2009
- Enhanced Protection against Bovine Tuberculosis after Coadministration ofMycobacterium bovisBCG with a Mycobacterial Protein Vaccine-Adjuvant Combination but Not after Coadministration of Adjuvant AloneClinical and Vaccine Immunology, 2008
- IL-23 and IL-17 in tuberculosisCytokine, 2008
- Genome plasticity of BCG and impact on vaccine efficacyProceedings of the National Academy of Sciences, 2007
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998